• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.

作者信息

Terasaki T, Sugiyama Y, Iga T, Sawada Y, Hanano M

出版信息

J Pharmacokinet Biopharm. 1985 Jun;13(3):265-87. doi: 10.1007/BF01065656.

DOI:10.1007/BF01065656
PMID:4087165
Abstract

Drug distribution kinetics in a noneliminating organ or tissue has been mathematically examined. The homogeneous (well-stirred) model regards the noneliminating organ or tissue as a homogeneous compartment in which the drug is equilibrated with that in the blood leaving the organ or tissue. The nonhomogeneous (tube) model views the noneliminating organ or tissue as comprising a number of parallel cylindrical tubes containing binding sites distributed homogeneously along these tubes. These two models are examined, considering the pseudo-distribution equilibrium phase after bolus injection and a linear binding condition. Although both models predict a similar tissue distribution under a variety of conditions, significant differences exist in the predictions of various pharmacokinetic parameters as a function of the drug distribution, such as blood flow, organ volume, slope of the terminal phase, and the tissue-to-blood partition coefficients. The predictability and limitations of these two models are explored. Distribution characteristics of the two models are also examined for adriamycin, actinomycin D, tetrachlorobiphenyl, hexachlorobiphenyl, digoxin, and ethoxybenzamide; no difference is observed. It is concluded that the assumption of a homogeneous (well-stirred) compartment is suitable for describing the drug distribution kinetics of these drugs.

摘要

相似文献

1
Theoretical consideration of drug distribution kinetics in a noneliminating organ: comparison between a "homogeneous (well-stirred)" model and "nonhomogeneous (tube)" model.
J Pharmacokinet Biopharm. 1985 Jun;13(3):265-87. doi: 10.1007/BF01065656.
2
Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.药代动力学概念——药物结合、表观分布容积和清除率。
Eur J Clin Pharmacol. 1981;20(4):299-305. doi: 10.1007/BF00618781.
3
Hepatic elimination of drugs with concentration-dependent serum protein binding.肝脏对具有浓度依赖性血清蛋白结合的药物的消除作用。
J Pharmacokinet Biopharm. 1984 Feb;12(1):67-81. doi: 10.1007/BF01063611.
4
A valid equation for the well-stirred perfusion limited physiologically based pharmacokinetic model that consistently accounts for the blood-tissue drug distribution in the organ and the corresponding valid equation for the steady state volume of distribution.一个有效的搅拌充分生理药代动力学模型的方程,该模型一致地考虑了器官中血液-组织的药物分布和相应的稳态分布容积的有效方程。
J Pharm Sci. 2010 Jan;99(1):475-85. doi: 10.1002/jps.21798.
5
Hemodynamic influences upon the variance of disposition residence time distribution of drugs.血流动力学对药物处置停留时间分布方差的影响。
J Pharmacokinet Biopharm. 1983 Feb;11(1):63-75. doi: 10.1007/BF01061768.
6
Drug availability to noneliminating tissues and sites of action following an intravenous dose.静脉给药后药物在非消除组织和作用部位的可获得性。
J Pharm Sci. 1986 Dec;75(12):1141-4. doi: 10.1002/jps.2600751205.
7
Exploration of PBPK Model-Calculation of Drug Time Course in Tissue Using IV Bolus Drug Plasma Concentration-Time Profile and the Physiological Parameters of the Organ.
J Pharm Sci. 2016 Aug;105(8):2453-8. doi: 10.1016/j.xphs.2016.04.019. Epub 2016 Jun 9.
8
A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.肝脏消除的弥散模型:2. 稳态考量——肝血流量、血液内结合以及肝细胞酶活性的影响
J Pharmacokinet Biopharm. 1986 Jun;14(3):261-88. doi: 10.1007/BF01106707.
9
Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.静脉平衡(“充分搅拌”)模型、窦状灌注(“平行管”)模型与特定双室开放模型的精确数学等效性。
Drug Metab Dispos. 1984 Jul-Aug;12(4):385-8.
10
Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling.在流量限制生理基于药代动力学模型中使用分配系数。
J Pharmacokinet Pharmacodyn. 2012 Aug;39(4):313-27. doi: 10.1007/s10928-012-9252-6. Epub 2012 May 26.

引用本文的文献

1
A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.一个纳入弥散概念的基于生理的全身药代动力学模型:短期和长期特征
J Pharmacokinet Pharmacodyn. 2001 Feb;28(1):27-55. doi: 10.1023/a:1011565602152.
2
A physiologically based pharmacokinetic model incorporating dispersion principles to describe solute distribution in the perfused rat hindlimb preparation.一种基于生理学的药代动力学模型,该模型纳入弥散原理以描述溶质在灌注大鼠后肢制剂中的分布。
J Pharmacokinet Biopharm. 1997 Aug;25(4):389-412. doi: 10.1023/a:1025788824946.
3
The uptake and elution of lignocaine and procainamide in the hindquarters of the sheep described using mass balance principles.

本文引用的文献

1
A review of the applications of physiologically based pharmacokinetic modeling.基于生理的药代动力学建模应用综述。
J Pharmacokinet Biopharm. 1979 Apr;7(2):127-45. doi: 10.1007/BF01059734.
2
Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.通过“试管”模型和“充分搅拌”模型评估血浆蛋白结合动力学对肝脏清除率的影响。
J Pharmacokinet Biopharm. 1981 Feb;9(1):15-26. doi: 10.1007/BF01059340.
3
In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models.
运用质量平衡原理描述了利多卡因和普鲁卡因酰胺在绵羊后肢中的摄取和洗脱情况。
J Pharmacokinet Biopharm. 1988 Feb;16(1):31-40. doi: 10.1007/BF01061861.
4
The assessment of bioavailability in the presence of nonlinear elimination.
J Pharmacokinet Biopharm. 1988 Jun;16(3):263-78. doi: 10.1007/BF01062137.
用于生理药代动力学模型的组织-血液分配系数的体外和体内评估。
J Pharmacokinet Biopharm. 1982 Dec;10(6):637-47. doi: 10.1007/BF01062545.
4
Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs.阿霉素组织分布机制的药代动力学研究:大鼠、兔和豚鼠体内各器官间及种属间组织与血浆分配系数的差异
J Pharm Sci. 1984 Oct;73(10):1359-63. doi: 10.1002/jps.2600731008.
5
Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant.阿霉素特征性组织分布的实验证据。以组织DNA浓度作为决定因素。
J Pharm Pharmacol. 1982 Sep;34(9):597-600. doi: 10.1111/j.2042-7158.1982.tb04804.x.
6
Preliminary pharmacokinetic model for adriamycin (NSC-123127).阿霉素(NSC - 123127)的初步药代动力学模型。
Cancer Chemother Rep. 1975 Jul-Aug;59(4):819-25.
7
Studies on the uptake and binding of propranolol by rat tissues.大鼠组织对普萘洛尔的摄取与结合研究。
J Pharmacol Exp Ther. 1977 Dec;203(3):621-9.
8
Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.
J Pharm Sci. 1977 Dec;66(12):1679-83. doi: 10.1002/jps.2600661206.
9
Correlation between in vitro and in vivo drug metabolism rate: oxidation of ethoxybenzamide in rat.体外与体内药物代谢速率之间的相关性:大鼠体内乙氧苯甲酰胺的氧化
J Pharmacokinet Biopharm. 1978 Aug;6(4):327-37. doi: 10.1007/BF01060096.
10
Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.
J Pharmacokinet Biopharm. 1977 Dec;5(6):655-80. doi: 10.1007/BF01059689.